V. Bozionelou

Trastuzumab decreases the incidence of clinical relapses in patients with early breast cancer presenting chemotherapy-resistant CK-19mRNA-positive circulating tumor cells: results of a randomized phase II study

Vasilis Georgoulias, V. Bozionelou, Sofia Agelaki et al. · Annals of Oncology · 2012 · 150 citations · Full text

Medicine, Oncology, Pharmacotherapy +12

Circulating HER2 mRNA-positive cells in the peripheral blood of patients with stage I and II breast cancer after the administration of adjuvant chemotherapy: evaluation of their clinical relevance

Stella Apostolaki, Maria Perraki, Athanasios Pallis et al. · Annals of Oncology · 2007 · 82 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Detection of CK-19 mRNA-positive cells in the peripheral blood of breast cancer patients with histologically and immunohistochemically negative axillary lymph nodes

E. Stathopoulos, Elias Sanidas, Maria Kafousi et al. · Annals of Oncology · 2005 · 59 citations · Full text

Medicine, Oncology, Pathology +15

Clinical relevance of circulating CK-19mRNA-positive tumour cells before front-line treatment in patients with metastatic breast cancer

N. Androulakis, Sofia Agelaki, Maria Perraki et al. · British Journal of Cancer · 2012 · 33 citations · Full text

Medicine, Molecular Medicine, Oncology +17

ZD1839, a novel, oral epidermal growth factor receptor-tyrosine kinase inhibitor, as salvage treatment in patients with advanced non-small cell lung cancer. Experience from a single center participating in a compassionate use program

Athanasios Pallis, D. Mavroudis, N. Androulakis et al. · Lung Cancer · 2003 · 33 citations

Medicine, Oncology, Pharmacology +12